abstract |
The invention provides compounds of formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof, in which A, n, p, q, R 1 , R 2 , R 3 and R 4 are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy. |